Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism

J Nephrol. 2017 Apr;30(2):297-301. doi: 10.1007/s40620-016-0319-0. Epub 2016 May 20.

Abstract

Hypomagnesemia is a common but often overlooked problem in hospitalized patients. Unrecognized hypomagnesemia can cause serious complications. The association of hypokalemia and hypocalcemia is strongly evocative of a magnesium deficiency. Research into the causes of hypomagnesemia is imperative, as it will definitely change the approach, treatment and prognosis. We report the case of a 65-year-old man with chronic hypocalcemia and hypokalemia associated with cerebellar syndrome, a solitary seizure and cerebellar hyperintensities on magnetic resonance imaging. After the detection and treatment of hypomagnesemia with oral supplements of magnesium and the replacement of pantoprazole with ranitidine, we observed immediate relief of the symptoms. In conclusion, in clinical practice, magnesium depletion should be investigated in elderly patients with hypocalcemia treated with proton pump inhibitors for many years, in particular in the presence of neurological disorders.

Keywords: Hypocalcemia; Hypokalemia; Hypomagnesemia; Hypoparathyroidism; Proton pump inhibitors.

Publication types

  • Case Reports

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles / adverse effects*
  • Aged
  • Biomarkers / blood
  • Cerebellar Diseases / chemically induced
  • Cerebellar Diseases / diagnosis
  • Dietary Supplements
  • Drug Substitution
  • Humans
  • Hypocalcemia / blood
  • Hypocalcemia / chemically induced
  • Hypocalcemia / diagnosis
  • Hypokalemia / blood
  • Hypokalemia / chemically induced
  • Hypokalemia / diagnosis
  • Hypoparathyroidism / blood
  • Hypoparathyroidism / chemically induced*
  • Hypoparathyroidism / diagnosis
  • Hypoparathyroidism / therapy
  • Magnesium / blood*
  • Male
  • Pantoprazole
  • Proton Pump Inhibitors / administration & dosage
  • Proton Pump Inhibitors / adverse effects*
  • Pyrrolidonecarboxylic Acid / administration & dosage
  • Ranitidine / administration & dosage
  • Seizures / chemically induced
  • Seizures / diagnosis
  • Treatment Outcome

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Biomarkers
  • Proton Pump Inhibitors
  • Ranitidine
  • Pantoprazole
  • Magnesium
  • Pyrrolidonecarboxylic Acid